Live Breaking News & Updates on Concord biotech ipo
Stay updated with breaking news from Concord biotech ipo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
So we expect to do better than what we have done historically, which was a CAGR growth of 18%. And this as economies of scale would kick in once a new site starts ramping up, we see our margin profiling being better than what it has been historically, which has been in the range of around 40%.
India Business News: India's Concord Biotech saw a 24.6% surge in its share prices to Rs 923 on Friday. With the biopharma company's IPO initially priced at Rs 741 rupees,
Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Concord Biotech IPO allotment date is August 11. Check allotment status on Link Intime India Private Ltd's website. Refund process starts on August 14. Listing date is August 18 on NSE and BSE. GMP is +159.
Analysts advised investors to subscribe to the issue given its complex product portfolio, presence in niche space, strong client relationship, and high entry barriers.